ORUKA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$96.87
+0.23%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+16.1%
3 months
+2.2%
6 months
+54.8%
1 year
+244.6%
Year to date
+219.6%
52-week range
$26.19 – $113.08
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$6.41B
P/E
-48.3
P/B
5.8
P/S
—
Revenue
$0
Net income
-$132.89M
Diluted EPS
-2.03
Gross margin
—
Net margin
—
Return on equity
-20.80%
Total debt
$2.55M
Cash
$268.47M
Free cash flow
-$101.15M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$41.21M | — | — | -$33.15M |
| Mar 31, 2026 | $0 | -$31.82M | — | — | -$23.65M |
| Dec 31, 2025 | $0 | -$29.58M | — | — | -$22.66M |
| Sep 30, 2025 | $0 | -$30.28M | — | — | -$21.7M |
| Jun 30, 2025 | $0 | -$24.57M | — | — | -$23.18M |
| Mar 31, 2025 | $0 | -$21M | — | — | -$20.88M |
| Dec 31, 2024 | $0 | -$25.78M | — | — | -$18.84M |
| Sep 30, 2024 | $0 | -$28.62M | — | — | -$35.03M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ORKA news
All market newsNo ticker-linked stories are in the current archive.